Fresenius gains swift antitrust approval for its 385 million-dollar American Access Care buy
Dialysis service and product provider Fresenius Medical Care has received regulatory clearance for its 385 million-dollar buy of Pennsylvania-based dialysis services group American Access Care Holdings, the Federal Trade Commission announced...To view the full article, register now.
Already a subscriber? Click here to view full article